Inflammatory bowel disease and cardiovascular diseases: a concise review

H Wu, T Hu, H Hao, MA Hill, C Xu… - European Heart Journal …, 2022 - academic.oup.com
Cardiovascular diseases (CVDs) remain the leading cause of morbidity and mortality
despite aggressive treatment of traditional risk factors. Chronic inflammation plays an …

[HTML][HTML] Inflammation in coronary artery disease-clinical implications of novel HDL-cholesterol–related inflammatory parameters as predictors

X Guo, L Ma - Coronary Artery Disease, 2023 - journals.lww.com
Coronary artery disease (CAD) is the leading cause of death worldwide. Inflammation and
atherosclerotic plaques are the primary pathological mechanisms of CAD. Upon stimulation …

Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts premature death in acute coronary syndromes

S Kraler, FA Wenzl, G Georgiopoulos… - European heart …, 2022 - academic.oup.com
Aims The lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) and its shedding
product [soluble LOX-1 (sLOX-1)] are implicated in atherosclerotic cardiovascular disease …

[HTML][HTML] The IL-1 family and its role in atherosclerosis

L González, K Rivera, ME Andia… - International Journal of …, 2022 - mdpi.com
The IL-1 superfamily of cytokines is a central regulator of immunity and inflammation. The
family is composed of 11 cytokines (with agonist, antagonist, and anti-inflammatory …

Cytokines and their role in cardiovascular diseases

H Haybar, B Bandar, E Torfi, A Mohebbi, N Saki - Cytokine, 2023 - Elsevier
The evaluation of diagnostic and prognostic biomarkers has always been a hot topic in
various diseases. Considering that cardiovascular diseases (CVDs) have the highest …

The role of interleukins in pathogenesis and prognosis of atrial fibrillation

ME Lotfi, PS Pezeshki, N Rezaei - Expert Review of Clinical …, 2023 - Taylor & Francis
Introduction Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia. Moreover, it is
mentioned as one of the important causes of death due to heart disease, which imposes an …

ESC/EAS guidelines for the detection, prevention, and treatment of individuals at risk of a first myocardial infarction: effect of 5 years of updates and the new SCORE2

D Sulman, M Zeitouni, J Silvain… - European Heart …, 2022 - academic.oup.com
Abstract Aims The European Society of Cardiology (ESC) has released three consecutive
guidelines within 5 years addressing cardiovascular prevention, risk scores, and cholesterol …

[HTML][HTML] Uncovering the Effect and Mechanism of Rhizoma Corydalis on Myocardial Infarction Through an Integrated Network Pharmacology Approach and …

J Li, J Wu, J Huang, Y Cheng, D Wang… - Frontiers in …, 2022 - frontiersin.org
Background: Myocardial infarction (MI), characterized by reduced blood flow to the heart, is
a coronary artery disorder with the highest morbidity and mortality among cardiovascular …

[HTML][HTML] Targeting interleukin-1 and interleukin-6: the time has come to aggressively address residual inflammatory risk

PM Ridker - Journal of the American College of Cardiology, 2020 - jacc.org
With the publication of CANTOS (the Canakinumab Anti-inflammatory Thrombosis Outcomes
Study) in 2017, the cardiovascular community received proof of principle that therapeutic …

[HTML][HTML] Soluble interleukin-2 receptor combined with interleukin-8 is a powerful predictor of future adverse cardiovascular events in patients with acute myocardial …

K Pan, C Xu, C Chen, S Chen, Y Zhang… - Frontiers in …, 2023 - frontiersin.org
Background Little is known about the role of interleukin (IL) in patients with acute myocardial
infarction (MI), especially soluble IL-2 receptor (sIL-2R) and IL-8. We aim to evaluate, in MI …